GlobalData on MSN3d
Thermo Fisher continues viral vector withdrawal; lays off 300 employees
The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
manilatimes2d
Appointment of Joint Corporate Broker and Joint Financial Adviser
Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...
Ever-Growing USA on MSN14h
Cell Line Development Process – Challenges and Best Practices
Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.
Stockhead on MSN2d
AdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creation
AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
GEN5d
Optimizing AAV Gene Delivery: Hitting the Target Safely and Effectively
Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.
TDAN3d
Data Speaks for Itself: Data Quality Management in the Age of Language Models
Unsurprisingly, my last two columns discussed artificial intelligence (AI), specifically the impact of language models (LMs) ...
FUJIKURA EXHIBITS MILLIMETER-WAVE PRODUCTS At MWC BARCELONA 2025
GHz millimeter-wave antenna board Demonstration setup 60 GHz millimeter-wave wireless communications module First presenta ...
Pharmaceutical Technology on MSN3d
Italian charity seeks EMA approval for rescued gene therapy
Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
EQS-News: GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...